NovaSeq 6000 Sequencing System is by far our most powerful instrument, designed to adapt to your needs.
Kits & Reagents
Study the coding and non-coding transcriptome with unparalleled flexibility
Selection & Planning Tools
A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing
Software & Informatics Products
Scalable multi-omics data management, analysis, and exploration
Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing
RNA library preparation with highly accurate results
Our leaders are pioneers of genetic research and clinical applications. They are deeply committed to scientific accessibility, data, and community.
Our 2021 Corporate Social Responsibility Report documents a year of positive impact
All Investor Information
New page replaces MyIllumina Technical Updates email
All Support Tools
Product Support Services
Study gene expression changes in cancer, RNA biomarkers of drug response, and more
Cancer Research Products
Microbial Genomics Research
NGS supports effective infectious disease surveillance strategies to reduce transmission and infection
Microbial Genomics Products
NGS in agriculture will allow for development of more productive and sustainable practices
Although Africa is the continent with the highest amount of genetic diversity, it is underrepresented in global genomic databases
Complex Disease Research Products
Simultaneously assess multiple biomarkers from numerous tumor types in a single NGS assay
Weighing the benefits of whole-genome sequencing vs targeted approaches
Reproductive Health Products
Genomic Answers for Kids project will use NGS to bring hope to families who have undergone multitudes of tests without progress
Genetic Health Products
The Illumina Connected Analytics (ICA) platform is the foundation on which a customized genomics analysis environment is built, managing and processing large amounts of heterogenous data sets.
The DRAGEN platform calls both small and large variants from population genetics studies with high precision and speed.
DRAGEN recently won the PrecisionFDA Truth Challenge V2 contest for Illumina reads in the Difficult-to-Map and All-Benchmark Regions categories.
SMNCopyNumberCaller enables accurate copy number calling of the highly similar SMN1 and SMN2 for spinal muscular atrophy diagnosis/carrier screening.
The Illumina team developed deep neural network algorithm, PrimateAI, to predict the clinical impact of human missense mutations.
SpliceAI, a 32-layer deep neural network, predicts splicing from pre-mRNA sequences and identifies cryptic splice variants in rare disease patients.
REViewer is a computational method for visualization of sequencing data in genomic regions containing long repeat expansions.
Paragraph is a graph aligner and variant caller that can accurately genotype known structural variants using the aligned sequence reads.
CYP2D6 metabolizes 21% of clinically used drugs. Cyrius resolves common SVs and sequence homology to paralog and genotypes CYP2D6 with 99.3% accuracy.